Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 10
- Markets & Stocks
Ananda and Celadon Raise Millions in New Funding, as Celadon Signs New Production Deal with Valeos, & More From Chill Brands
Ananda Developments [stock_market_widget type=”chart” template=”line” assets=”ANA.AQ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The Aquis Stock Exchange-listed CBD life sciences company announced this week that it has successfully raised £2.1m through a new subscription of shares.
- Markets & Stocks
Argent BioPharma Sees 74% Sales Decline, Cantourage Enjoys 62% Sales Increase, & Organigram Progresses With BAT Investment
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June 30, 2024, revealing a sharp drop in revenues but a reigning in of net losses compared to the previous year.
- Markets & Stocks
Jazz Fails Phase 3 Trial in Japan, BAT Set to See Growth From Cannabis Investment, & DanCann Pharma Reports First Profit
Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”JAZZ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase 3 clinical trial in Japan.
- Markets & Stocks
Synbiotic Hails Sales Growth Post-CanG, Stenocare Halves Sales Forecast for 2024, & Argent Bio. Delists From ASX
Synbiotic [stock_market_widget type=”chart” template=”line” assets=”SBX.F” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] German cannabis group Synbiotic published an update on its eclectic portfolio of businesses this week, seeing sales rise across the board following the passage of CanG.
- Markets & Stocks
Celadon Sees 60% Drop in Stock Price as Funding Delayed, Hellenic Avoids Liquidation, & Flora Lists in Germany
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The London Stock Exchange-listed medical cannabis operator saw its stock drop by nearly 60% this week, resulting in a dramatic downturn in its market capitalisation, after announcing that it has been forced to weather numerous delays in funding.
- Markets & Stocks
Hellenic Faces Potential Liquidation As Winding-Up Petition Filed, Ananda Moves to Senior Segment, & More from Phytanix Bio
Hellenic Dynamics [stock_market_widget type=”chart” template=”line” assets=”HELD.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Hellenic Dynamics is battling to stay afloat after receiving a ‘winding-up petition’ from one of its creditors, requiring it to pay its debts and accrued interest in full or face potential liquidation, and has seen its shares temporarily…
- Markets & Stocks
Tilray Gets First New German Domestic Cultivation Licence, Dalgety Seeks £6m Investment, & More from Celadon
Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] US cannabis giant Tilray has become the first company in half a decade to recieve a new domestic cannabis cultivation licence in Germany.
- Markets & Stocks
Cannabis Investment Insights From Cannabis Europa, Ananda Stock Jumps on Pre-Clinical Results, & More from Cannovum
Cannabis Europa – insights from leading cannabis investors Last week saw European cannabis industry leaders flock to London to attend this year’s Cannabis Europa conference.
- Markets & Stocks
Chill Brands Ousted Directors Transferred $400k to Personal Accounts While CEO Absent, & Germany’s CanG Changes Boost Cannovum’s Stock
Chill Brands [stock_market_widget type=”chart” template=”line” assets=”CHLL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Chill Brands’ ongoing boardroom debacle took another dramatic turn this week following revelations that its ousted directors acted ‘to defraud the business’ while its CEO was temporarily suspended.
- Markets & Stocks
Chill Brands CEO Reinstated as Directors Ousted, Voyager Life Sees 2nd Deal Fall Through, & More From OCT
Chill Brands [stock_market_widget type=”chart” template=”line” assets=”CHLL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The CBD and vaping retailer Chill Brands has voted to oust two of its longest-standing directors as part of an investor coup.
- Markets & Stocks
IM Cannabis Merger Scrapped, Cel AI Gets a New CEO, & More from Intercure
Cel AI [stock_market_widget type=”chart” template=”line” assets=”CLAI.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Cel AI, formely Cellular Goods, has published its interim results as it continues to shift its focus away from its struggling cannabis operations and towards new technologies.
- Markets & Stocks
Akanda Implements 2nd Stock Split Amid Debt Woes, DanCann Pharma Earnings Fall Due to Strategy Change, & More From Celadon
Akanda Corp [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Akanda Corp has announced plans to implement another reverse stock split, its second to date, following a non-compliance notice from NASDAQ last week.
